Directorio de personas
Luis Brieva Ruiz

Luis Brieva Ruiz

Grado: Doctor/a

973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3812-2011

Grupos

Publicaciones

  • Comi G; Jeffery D; Kappos L; Montalban X; Boyko A; Rocca MA; Filippi M; ALLEGRO Study Group

    Placebo-controlled trial of oral laquinimod for multiple sclerosis.

    NEW ENGLAND JOURNAL OF MEDICINE 366 1000-1009. .

    [doi:10.1056/NEJMoa1104318]

  • Purroy, Francisco; Montserrat, Josep; Begue, Robert; Isabel Gil, Maria; Quilez, Alejandro; Sanahuja, Jordi; Brieva, Luis; Pardina, Marina; Pinol-Ripoll, Gerard

    Higher carotid intima media thickness predicts extracranial vascular events and not stroke recurrence among transient ischemic attack patients

    INTERNATIONAL JOURNAL OF STROKE 7 125-132. .

    [doi:10.1111/j.1747-4949.2011.00764.x]

  • Tur, Carmen; Montalban, Xavier; Tintore, Mar; Nos, Carlos; Rio, Jordi; Xavier Aymerich, Francesc; Brieva, Luis; Tellez, Nieves; Perkal, Hector; Comabella, Manuel; Galan, Ingrid; Calle, David; Sastre-Garriga, Jaume; Rovira, Alex

    Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis Five-Year Clinical Trial Follow-up

    ARCHIVES OF NEUROLOGY 68 1421-1427. .

  • Tur C; Montalban X; Tintoré M; Nos C; Río J; Aymerich FX; Brieva L; Téllez N; Perkal H; Comabella M; Galán I; Calle D; Sastre-Garriga J; Rovira A

    Interferon ß-1b for the treatment of primary progressive multiple sclerosis: five-year clinical trial follow-up.

    ARCHIVES OF NEUROLOGY 68 1421-1427. .

    [doi:10.1001/archneurol.2011.241]

  • Fernandez, Oscar; Fernandez, Victoria; Baumstarck-Barrau, Karine; Munoz, Luis; Gonzalez Alvarez, Maria del Mar; Carlos Arrabal, Jose; Leon, Antonio; Alonso, Ana; Carlos Lopez-Madrona, Jose; Bustamante, Rafael; Luque, Gloria; Guerrero, Miguel; di Cantogno, Elisabetta Verdun; Auquier, Pascal; MusiQoL Study Grp Spain

    Validation of the spanish version of the Multiple Sclerosis International Quality of Life (Musiqol) questionnaire.

    BMC NEUROLOGY 11 127-127. .

    [doi:10.1186/1471-2377-11-127]

  • Arroyo, E.; Grau, C.; Ramo-Tello, C.; Parra, J.; Sanchez-Solino, O.; GAP Study Grp

    Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project.

    EUROPEAN NEUROLOGY 65 59-67. .

    [doi:10.1159/000323216]

  • Purroy, F.; Begue, R.; Gil, M. I.; Quilez, A.; Sanahuja, J.; Brieva, L.; Pinol-Ripoll, G.

    Patterns of diffusion-weighted magnetic resonance imaging associated with etiology improve the accuracy of prognosis after transient ischaemic attack.

    EUROPEAN JOURNAL OF NEUROLOGY 18 121-128. .

    [doi:10.1111/j.1468-1331.2010.03080.x]

  • Devonshire, V.; Lapierre, Y.; Macdonell, R.; Ramo-Tello, C.; Patti, F.; Fontoura, P.; Suchet, L.; Hyde, R.; Balla, I.; Frohman, E. M.; Kieseier, B. C.; GAP Study Grp

    The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis

    EUROPEAN JOURNAL OF NEUROLOGY 18 69-77. .

    [doi:10.1111/j.1468-1331.2010.03110.x]

  • Purroy F; Quílez-Martínez A; Pardina M; Suárez-Luis I; Sanahuja-Montesinos J; Brieva L; Piñol-Ripoll G

    Qué puede aportar la determinación del grosor íntima-media carotídeo al proceso diagnóstico del ataque isquémico transitorio?

    REVISTA DE NEUROLOGIA 51 721-728. .

  • Purroy, Francisco; Pinol-Ripoll, Gerard; Quilez, Alejandro; Sanahuja, Jordi; Brieva, Luis; Suarez Luis, Idalmis

    Validación de las escalas ABCDI y ABCD2I en el registro de pacientes con ataque isquémico transitorio de Lleida (REGITELL).

    MEDICINA CLINICA 135 351-356. .

    [doi:10.1016/j.medcli.2009.10.054]

  • Bosma, L. V. A. E.; Kragt, J. J.; Brieva, L.; Khaleeli, Z.; Montalban, X.; Polman, C. H.; Thompson, A. J.; Tintore, M.; Uitdehaag, B. M. J.

    Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?

    MULTIPLE SCLEROSIS JOURNAL 16 862-867. .

    [doi:10.1177/1352458510370464]

  • Otero, S.; Batlle, J.; Bonaventura, I.; Brieva, Ll; Bufill, E.; Cano, A.; Carmona, O.; Escartin, A.; Marco, M.; Moral, E.; Munteis, E.; Nos, C.; Pericot, I.; Perkal, H.; Ramio-Torrenta, Ll; Ramo-Tello, C.; Saiz, A.; Sastre-Garriga, J.; Tintore, M.; Vaque, J.; Montalban, X.

    Multiple sclerosis epidemiological situation update: pertinence and set-up of a population based registry of new cases in Catalonia

    REVISTA DE NEUROLOGIA 50 623-633. .

Proyectos

  • EMCOVID-19: Esclerosis Múltiple y COVID-19
  • "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
  • UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO